NasdaqGS:RXRXBiotechs
Is Now the Moment to Reassess Recursion After Latest Platform Partnerships and Market Surge?
Thinking about what to do with Recursion Pharmaceuticals stock? You are not alone. The last few months have given shareholders a rollercoaster to ride, marked by bursts of optimism and hints of concern. In just the past week, the stock nudged up 3.1%, but step back a little further and the swings get much sharper. Recursion is up an impressive 23.8% in the last month. However, peel back the curtain on the longer-term picture and the story cools: year-to-date, shares are still down by 16.2%,...